BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6968922)

  • 21. [Cellular immunity in melanomalignome (author's transl)].
    Fritz J; Grond K; Tilz GP
    Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.
    Strohal R; Paucz L; Pehamberger H; Stingl G
    Cancer Res; 1994 Sep; 54(17):4734-9. PubMed ID: 8062272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Agarose test of leukocyte migration inhibition].
    Kaszubowski P; Wysocki J
    Wiad Lek; 1979 Nov; 32(22):1621-3. PubMed ID: 395757
    [No Abstract]   [Full Text] [Related]  

  • 24. Regression of malignant melanoma as a manifestation of a cellular immunity response.
    Lloyd OC
    Proc R Soc Med; 1969 Jun; 62(6):543-5. PubMed ID: 5802725
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings: cellular immunity to malignant melanoma.
    Grant RM; Cochran AJ; Thomas CE; Mackie RM; Cameron-Mowat DE; Spilg WG; Norman JN
    Br J Surg; 1973 Nov; 60(11):905. PubMed ID: 4752760
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative study of natural cytotoxicity and the leukocyte migration inhibition in human melanoma stages I and II.
    Kristensen E
    J Cancer Res Clin Oncol; 1980; 96(2):181-91. PubMed ID: 7391115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunobiology of human cutaneous melanoma.
    Cochran AJ; Wen DR; Stene M; Fairhurst MV; Hoon DS
    Prog Clin Biol Res; 1988; 256():597-618. PubMed ID: 3368501
    [No Abstract]   [Full Text] [Related]  

  • 28. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
    Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
    Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immunity in malignant melanoma.
    Cochran AJ; Jehn UW; Gothoskar BP
    Lancet; 1972 Jun; 1(7764):1340-1. PubMed ID: 4113434
    [No Abstract]   [Full Text] [Related]  

  • 30. [Leukocyte migration inhibition test methods in capillary tubes for the detection of hyperactive cell types in vitro].
    Mkrtchian VA; Zakarian SA; Chobanian EN
    Zh Eksp Klin Med; 1974; 14(3):11-3. PubMed ID: 4421644
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
    Sansoni P; Rossetti A; Valente G; Butturini U
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of safe-intensity laser irradiation on the immune system].
    Kupin VI; Sorokin AM; Ivanov AV; Lapteva RM; Polevaia EB
    Sov Med; 1985; (7):8-12. PubMed ID: 3877990
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cell-mediated BCG-diagnosis using a multipuncture apparatus in melanoma].
    Wolf M
    Dermatol Monatsschr; 1976 Sep; 162(9):756-7. PubMed ID: 992184
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison between results of leukocyte migration inhibition test and skin hypersensitivity of tuberculin in man].
    Claudy A; Thivolet J; Valancogne A; Schmitt D
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):826-30. PubMed ID: 5128513
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunotherapy of advanced or metastatic melanoma.
    Cebon J; Gedye C; John T; Davis ID
    Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the antigenicity of melanotic and amelanotic melanoma cells after the release of surface glycoproteins by trypsin.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):641-4. PubMed ID: 7192976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunology of malignant melanoma. Current data].
    Pavie-Fischer J; Kourilsky FM
    Rev Prat; 1975 Nov; 25(51):4027-8, 4031-3. PubMed ID: 1209142
    [No Abstract]   [Full Text] [Related]  

  • 38. [Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system].
    Richter G; Heidenbluth I; Heidelbach U
    Dermatol Monatsschr; 1982 Dec; 168(12):797-806. PubMed ID: 7169101
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of immunologic reactions against skin tissues in psoriasis].
    Sizov IE
    Vestn Dermatol Venerol; 1979 May; (5):15-20. PubMed ID: 313128
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative examinations of the effect of general and local anesthesia upon the T-lymphocytes in melanoma operations (author's transl)].
    Seebacher C; Bässler E
    Arch Geschwulstforsch; 1981; 51(2):179-86. PubMed ID: 6973960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.